Norges Bank’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1M | Buy |
+987,674
| New | +$32.1M | ﹤0.01% | 1099 |
|
|
2025
Q1 | – | Sell |
-1,100,286
| Closed | -$90.1M | – | 1199 |
|
|
2024
Q4 | $90.1M | Buy |
+1,100,286
| New | +$90.1M | 0.01% | 735 |
|
|
2024
Q3 | – | Sell |
-984,464
| Closed | -$74.3M | – | 1251 |
|
|
2024
Q2 | $74.3M | Sell |
984,464
-61,568
| -6% | -$4.65M | 0.01% | 750 |
|
|
2024
Q1 | $71.5M | Buy |
1,046,032
+130,520
| +14% | +$8.92M | 0.01% | 781 |
|
|
2023
Q4 | $57.5M | Buy |
915,512
+129,969
| +17% | +$8.16M | 0.01% | 841 |
|
|
2023
Q3 | $40M | Buy |
785,543
+34,509
| +5% | +$1.76M | 0.01% | 939 |
|
|
2023
Q2 | $37.5M | Buy |
751,034
+334,398
| +80% | +$16.7M | 0.01% | 995 |
|
|
2023
Q1 | $15.6M | Buy |
416,636
+290,757
| +231% | +$10.9M | ﹤0.01% | 1393 |
|
|
2022
Q4 | $6.04M | Buy |
+125,879
| New | +$6.04M | ﹤0.01% | 1725 |
|
|
2021
Q1 | – | Sell |
-20,000
| Closed | -$531K | – | 2182 |
|
|
2020
Q4 | $531K | Hold |
20,000
| – | – | ﹤0.01% | 2074 |
|
|
2020
Q3 | $988K | Hold |
20,000
| – | – | ﹤0.01% | 2032 |
|
|
2020
Q2 | $632K | Buy |
+20,000
| New | +$632K | ﹤0.01% | 2039 |
|